We have ranked, sorted, and summarized the latest research from top journals.
How antipsychotic drugs like clozapine affect blood cancer risk: Latest findings to know when treating schizophrenia
The Lancet Psychiatry
June 23, 2022
Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis
New England Journal of Medicine
April 08, 2022
Atypical Spitz Tumors: An epidemiological, clinical and dermoscopic multicenter study with 16-year follow-up
Clinical and Experimental Dermatology
February 14, 2022
Neoadjuvant nivolumab and chemotherapy in patients with locally advanced non- small cell lung cancer: A retrospective...
Cancer Management and Research
February 14, 2022
Risk factors associated with venous and arterial neonatal thrombosis in the intensive care unit: A multicenter...
The Lancet Haematology
February 14, 2022
Autologous dendritic cell immunotherapy plus chemotherapy in metastatic castration-resistant prostate cancer
JAMA
February 14, 2022
Effect of a symptom monitoring intervention for patients hospitalized with advanced cancer
JAMA
February 14, 2022
Statin use and reduced hepatocellular carcinoma risk in patients with non- alcoholic fatty liver disease
Clinical Gastroenterology and Hepatology
February 14, 2022
Echocardiography for the diagnosis of CTRCD in women with early-stage breast cancer
JAMA
February 11, 2022
High local failure rates despite high margin‐negative resection rates in a cohort of borderline resectable and...
Cancer Medicine
February 11, 2022
Clinical characteristics and thyroid function in complete hydatidiform mole complicated by hyperthyroidism
Gynecologic Oncology
February 11, 2022
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: A...
The Lancet: Gastroenterology & Hepatology
February 11, 2022
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: A single-arm, open-label, phase 2 trial
The Lancet: Gastroenterology & Hepatology
February 11, 2022
Carboplatin-based adjuvant chemotherapy vs observation after radical cystectomy in patients with pN1-3 urothelial...
World Journal of Urology
February 11, 2022
Outcomes in men with metastatic castration-resistant prostate cancer who received sipuleucel-T and no immediate...
Prostate Cancer & Prostatic Diseases
February 11, 2022
Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil...
Alimentary Pharmacology and Therapeutics
February 10, 2022
Pancreatic cancer-associated diabetes mellitus is characterized by reduced β-cell secretory capacity, rather than...
Diabetes Research and Clinical Practice
February 10, 2022
Alcohol dehydrogenase expression patterns in normal prostate, benign prostatic hyperplasia, and prostatic adenocarcinoma...
The Prostate
February 10, 2022
A multicenter phase II trial evaluating the efficacy of bevacizumab plus mFOLFOX6 for R0 surgical resection in advanced...
HPB
February 10, 2022
Age-stratified outcomes after radical prostatectomy in a randomized setting (LAP-01): Do younger patients have more to...
World Journal of Urology
February 09, 2022
New Featured Articles
We Recommend For You
-
Chemobrain: Our Current Understanding
In the News
-
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III...
Clinical Trial
-
Role of downregulated miR-133a-3p expression in bladder cancer: A bioinformatics...
Journal Summary | October 16, 2017
-
An etiologic prediction model incorporating biomarkers to predict the bladder...
Journal Summary | August 31, 2017
-
2017 was a record-setting year for FDA approvals in oncology
In the News
-
Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer
Clinical Trial
-
The burden of cystoscopic bladder cancer surveillance: Anxiety, discomfort, and...
Journal Summary | August 09, 2017
-
Northeastern Section of the American Urological Association 69th Annual Mee
Conference
-
The safety and efficacy of front-firing green-light laser endoscopic en bloc...
Journal Summary | September 27, 2017
-
Lifetime inactivity may be an independent risk factor for renal and bladder...
In the News